22nd Century Sells 15.8M Shares for $4.7M Under Existing ATM, Adds $18.8M Capacity
XXII is trading near its 52-week low of $0.176 (11% above the low) on elevated volume (36× avg).
Summary
22nd Century sold 15.8 million shares for about $4.7 million in October under its existing Needham ATM and filed a new prospectus supplement for up to $18.8 million more, a substantial dilution of its 19.2 million shares outstanding.
Key Events · Financing and Capital Events · XXII
-
October ATM Sales of 15.8M Shares
Sold 15,785,757 shares during October 2026 for gross proceeds of approximately $4.7 million under the Sales Agreement with Needham & Company.
-
New $18.8M ATM Capacity Filed
Filed a prospectus supplement to the S-3 permitting sales of up to $18,800,000 of common stock in the at-the-market offering.
-
Dilution Against 19.2M Shares Outstanding
The 15,785,757 shares sold in October compare with 19,202,198 shares outstanding as of October 23, 2026 — a large increase in the share count in one month.
-
Existing Program, Not a New Launch
The Sales Agreement dates to November 4, 2025, and the S-3 was declared effective April 10, 2026; this is an update to an existing ATM, not a new program.
Analysis · XXII · Manufacturing
The company is drip-feeding stock into the market through its existing Needham at-the-market program. In October alone it sold 15,785,757 shares for about $4.7 million — against 19,202,198 shares outstanding, that is a large share-count increase in a single month, and the new prospectus supplement keeps up to $18.8 million of additional capacity available. The cash extends runway for a company that previously disclosed going-concern doubt, but existing holders absorb the dilution. The average realized price of roughly $0.30 per share (4.7M / 15.8M) is above today's $0.1942 quote, so the stock has fallen since those sales.
How filings like this one have moved
In the 30 days to Oct 23, 2026, 29.2% of the 1549 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XXII was trading at $0.19 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $141.2K. The 52-week trading range was $0.18 to $540.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.